RNA-seq analysis revealed that TACSTD2 primarily enhances the biological functions of ovarian cancer cells through the PI3K-AKT, MAPK, Calcium, Rap1 signalling pathways (Figure 6A). This evidence concerns the gene AKT1 and ovarian cancer.